» Articles » PMID: 37846096

Evaluating Mixtures of Urinary Phthalate Metabolites and Serum Per-/Polyfluoroalkyl Substances in Relation to Adolescent Hair Cortisol: The HOME Study

Overview
Journal Am J Epidemiol
Specialty Public Health
Date 2023 Oct 17
PMID 37846096
Authors
Affiliations
Soon will be listed here.
Abstract

Results of toxicological studies indicate that phthalates and per-/polyfluoroalkyl substances (PFAS), 2 classes of endocrine-disrupting chemicals, may alter the functioning of the hypothalamic-pituitary-adrenocortical (HPA) axis. We evaluated the associations of urinary phthalate metabolites and serum PFAS during gestation and childhood with adolescent hair cortisol concentrations (pg/mg hair) at age 12 years, an integrative marker of HPA axis activity (n = 205 mother-child pairs; Cincinnati, Ohio; enrolled 2003-2006). We used quantile-based g-computation to estimate associations between mixtures of urinary phthalate metabolites or serum PFAS and hair cortisol. We also examined whether associations of individual phthalate metabolites or PFAS with cortisol varied by the timing of exposure. We found that a 1-quartile increase in all childhood phthalate metabolites was associated with 35% higher adolescent hair cortisol (phthalate mixture ψ = 0.13; 95% confidence interval: 0.03, 0.22); these associations were driven by monoethyl phthalate, monoisobutyl phthalate, and monobenzyl phthalate. We did not find evidence that phthalate metabolites during gestation or serum PFAS mixtures were related to adolescent hair cortisol concentrations. We found suggestive evidence that higher childhood concentrations of individual PFAS were related to higher and lower adolescent hair cortisol concentrations. Our results suggest that phthalate exposure during childhood may contribute to higher levels of chronic HPA axis activity.

References
1.
Crowley R, Woods C, Hughes B, Gray J, McCarthy T, Taylor A . Increased central adiposity and decreased subcutaneous adipose tissue 11β-hydroxysteroid dehydrogenase type 1 are associated with deterioration in glucose tolerance-A longitudinal cohort study. Clin Endocrinol (Oxf). 2019; 91(1):72-81. DOI: 10.1111/cen.13939. View

2.
Li N, Liu Y, Papandonatos G, Calafat A, Eaton C, Kelsey K . Gestational and childhood exposure to per- and polyfluoroalkyl substances and cardiometabolic risk at age 12 years. Environ Int. 2021; 147:106344. PMC: 7856172. DOI: 10.1016/j.envint.2020.106344. View

3.
Bloom M, Wenzel A, Brock J, Kucklick J, Wineland R, Cruze L . Racial disparity in maternal phthalates exposure; Association with racial disparity in fetal growth and birth outcomes. Environ Int. 2019; 127:473-486. DOI: 10.1016/j.envint.2019.04.005. View

4.
Guenther P, Casavale K, Reedy J, Kirkpatrick S, Hiza H, Kuczynski K . Update of the Healthy Eating Index: HEI-2010. J Acad Nutr Diet. 2013; 113(4):569-80. PMC: 3810369. DOI: 10.1016/j.jand.2012.12.016. View

5.
La Merrill M, Vandenberg L, Smith M, Goodson W, Browne P, Patisaul H . Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification. Nat Rev Endocrinol. 2019; 16(1):45-57. PMC: 6902641. DOI: 10.1038/s41574-019-0273-8. View